PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.34%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$891M
AUM Growth
+$891M
(+10%)
Cap. Flow
-$1.62M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
160
New
50
Increased
18
Reduced
30
Closed
32
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$28.3M |
| 2 |
Heron Therapeutics
HRTX
|
$24.5M |
| 3 |
PTC Therapeutics
PTCT
|
$17.6M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$16.2M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$15.1M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$42.3M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$31.8M |
| 3 |
MannKind Corp
MNKD
|
$19.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$16.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$14.6M |
Sector Composition
| 1 | Healthcare | 88.32% |
| 2 | Technology | 0.04% |
| 3 | Industrials | 0.02% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
26
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $10.8M | 1.13% |
97,011
+40,409
| +71% | +$4.49M |
|
|
AVDL
27
Avadel Pharmaceuticals
AVDL
$1.42B
| $10.7M | 1.13% |
+800,000
| New | +$10.7M |
|
|
ECYT
28
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $10.4M | 1.09% |
435,000
-236,300
| -35% | -$5.63M |
|
|
SPNC
29
DELISTED
Spectranetics Corp
SPNC
| $10.1M | 1.06% |
332,554
-13,700
| -4% | -$415K |
|
30
Incyte
INCY
$17B
| $9.84M | 1.03% |
183,800
-85,000
| -32% | -$4.55M |
|
|
ISEE
31
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.94M | 0.94% |
250,000
+175,000
| +233% | +$6.25M |
|
|
ITMN
32
DELISTED
INTERMUNE INC
ITMN
| $8.7M | 0.91% |
+260,000
| New | +$8.7M |
|
33
HCA Healthcare
HCA
$95.4B
| $7.88M | 0.83% |
+150,000
| New | +$7.88M |
|
|
CHTP
34
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $7.19M | 0.76% |
1,301,639
-400,000
| -24% | -$2.21M |
|
|
DSCI
35
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $6.76M | 0.71% |
+532,800
| New | +$6.76M |
|
36
Insmed
INSM
$30.3B
| $6.47M | 0.68% |
+340,000
| New | +$6.47M |
|
|
ADYX
37
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $6.47M | 0.68% |
784,594
+227,103
| +41% | +$1.87M |
|
|
TRVN
38
DELISTED
Trevena, Inc.
TRVN
| $6.05M | 0.64% |
+770,000
| New | +$6.05M |
|
|
RLYP
39
DELISTED
RELYPSA INC COM
RLYP
| $5.4M | 0.57% |
181,200
-160,000
| -47% | -$4.77M |
|
40
Sonida Senior Living
SNDA
$477M
| $5.26M | 0.55% |
202,500
-6,253
| -3% | -$163K |
|
41
Arrowhead Research
ARWR
$3.84B
| $5.21M | 0.55% |
+317,300
| New | +$5.21M |
|
|
ENZY
42
DELISTED
Enzymotec Ltd
ENZY
| $4.72M | 0.5% |
+214,219
| New | +$4.72M |
|
|
KERX
43
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.69M | 0.49% |
+275,000
| New | +$4.69M |
|
44
Globus Medical
GMED
$7.94B
| $4.52M | 0.47% |
+170,000
| New | +$4.52M |
|
|
AERI
45
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.48M | 0.47% |
211,518
-88,482
| -29% | -$1.87M |
|
|
SHPG
46
DELISTED
Shire pic
SHPG
| $4.46M | 0.47% |
30,000
+20,000
| +200% | +$2.97M |
|
47
Gilead Sciences
GILD
$140B
| $3.54M | 0.37% |
50,000
| – | – |
|
48
AbbVie
ABBV
$374B
| $3.44M | 0.36% |
67,000
-283,000
| -81% | -$14.5M |
|
49
Alnylam Pharmaceuticals
ALNY
$58.6B
| $3.36M | 0.35% |
+50,000
| New | +$3.36M |
|
|
GRCE
50
Grace Therapeutics, Inc. Common Stock
GRCE
$41.1M
| $3.3M | 0.35% |
2,869,447
-1,520,238
| -35% | -$1.75M |
|